Cargando…
Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: Probable role of NF-kB activation
Diabetes is considered as the most common metabolic disease affecting millions of people all around the world. Use of natural herbal medicines can be effective in treating diabetes. Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) a polyphenolic alkanone extracted from ginger has a broad spectru...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260481/ https://www.ncbi.nlm.nih.gov/pubmed/30532634 http://dx.doi.org/10.1016/j.jsps.2018.07.001 |
_version_ | 1783374802396905472 |
---|---|
author | Ahmad, Bilal Rehman, Muneeb U. Amin, Insha Mir, Manzoor ur Rahman Ahmad, Sheikh Bilal Farooq, Adil Muzamil, Showkeen Hussain, Ishraq Masoodi, Mubashir Fatima, Bilques |
author_facet | Ahmad, Bilal Rehman, Muneeb U. Amin, Insha Mir, Manzoor ur Rahman Ahmad, Sheikh Bilal Farooq, Adil Muzamil, Showkeen Hussain, Ishraq Masoodi, Mubashir Fatima, Bilques |
author_sort | Ahmad, Bilal |
collection | PubMed |
description | Diabetes is considered as the most common metabolic disease affecting millions of people all around the world. Use of natural herbal medicines can be effective in treating diabetes. Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) a polyphenolic alkanone extracted from ginger has a broad spectrum of pharmacological properties and thus can be used as a promising candidate against various ailments. In the current study we aimed at demonstrating the protective effect of zingerone against diabetes mellitus and elucidating its possible mechanism. Five groups of animals (I-V) were made with ten animals each. Group I (control) was given normal saline orally. Group II (diabetic positive control) was given alloxan at the dose rate of 100 mg/kg bwt once. Group III and IV was given alloxan once at the dose rate of 100 mg/kg bwt. and received oral treatment of zingerone at a dose rate of 50 and 100 mg/kg bwt respectively daily for 21 days. Group V was given alloxan at the dose of 100 mg/kg bwt. and was treated with standard drug glibenclamide at the dose rate of 4.5 mg/kg bwt. daily for 21 days. According to our findings we confirmed that zingerone restrained the alloxan induced oxidative stress by increasing the activity of reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX) and reducing the peroxidative damage. We also confirmed that zingerone suppressed the level of redox sensitive transcription factor NFκB and downregulated other downstream inflammatory cytokines like interleukins (IL1-β IL-2, IL-6) and tumor necrosis factor alpha (TNF-α). Moreover, the experimental findings suggested that zingerone improved the insulin levels. Taken together our results indicated that zingerone effectively ameliorated the diabetes induced complications which provide a strong theoretical basis for zingerone to be used clinically for treatment of diabetes. |
format | Online Article Text |
id | pubmed-6260481 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-62604812018-12-07 Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: Probable role of NF-kB activation Ahmad, Bilal Rehman, Muneeb U. Amin, Insha Mir, Manzoor ur Rahman Ahmad, Sheikh Bilal Farooq, Adil Muzamil, Showkeen Hussain, Ishraq Masoodi, Mubashir Fatima, Bilques Saudi Pharm J Article Diabetes is considered as the most common metabolic disease affecting millions of people all around the world. Use of natural herbal medicines can be effective in treating diabetes. Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) a polyphenolic alkanone extracted from ginger has a broad spectrum of pharmacological properties and thus can be used as a promising candidate against various ailments. In the current study we aimed at demonstrating the protective effect of zingerone against diabetes mellitus and elucidating its possible mechanism. Five groups of animals (I-V) were made with ten animals each. Group I (control) was given normal saline orally. Group II (diabetic positive control) was given alloxan at the dose rate of 100 mg/kg bwt once. Group III and IV was given alloxan once at the dose rate of 100 mg/kg bwt. and received oral treatment of zingerone at a dose rate of 50 and 100 mg/kg bwt respectively daily for 21 days. Group V was given alloxan at the dose of 100 mg/kg bwt. and was treated with standard drug glibenclamide at the dose rate of 4.5 mg/kg bwt. daily for 21 days. According to our findings we confirmed that zingerone restrained the alloxan induced oxidative stress by increasing the activity of reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX) and reducing the peroxidative damage. We also confirmed that zingerone suppressed the level of redox sensitive transcription factor NFκB and downregulated other downstream inflammatory cytokines like interleukins (IL1-β IL-2, IL-6) and tumor necrosis factor alpha (TNF-α). Moreover, the experimental findings suggested that zingerone improved the insulin levels. Taken together our results indicated that zingerone effectively ameliorated the diabetes induced complications which provide a strong theoretical basis for zingerone to be used clinically for treatment of diabetes. Elsevier 2018-12 2018-07-29 /pmc/articles/PMC6260481/ /pubmed/30532634 http://dx.doi.org/10.1016/j.jsps.2018.07.001 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Ahmad, Bilal Rehman, Muneeb U. Amin, Insha Mir, Manzoor ur Rahman Ahmad, Sheikh Bilal Farooq, Adil Muzamil, Showkeen Hussain, Ishraq Masoodi, Mubashir Fatima, Bilques Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: Probable role of NF-kB activation |
title | Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: Probable role of NF-kB activation |
title_full | Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: Probable role of NF-kB activation |
title_fullStr | Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: Probable role of NF-kB activation |
title_full_unstemmed | Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: Probable role of NF-kB activation |
title_short | Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: Probable role of NF-kB activation |
title_sort | zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) protects against alloxan-induced diabetes via alleviation of oxidative stress and inflammation: probable role of nf-kb activation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260481/ https://www.ncbi.nlm.nih.gov/pubmed/30532634 http://dx.doi.org/10.1016/j.jsps.2018.07.001 |
work_keys_str_mv | AT ahmadbilal zingerone44hydroxy3methylphenylbutan2oneprotectsagainstalloxaninduceddiabetesviaalleviationofoxidativestressandinflammationprobableroleofnfkbactivation AT rehmanmuneebu zingerone44hydroxy3methylphenylbutan2oneprotectsagainstalloxaninduceddiabetesviaalleviationofoxidativestressandinflammationprobableroleofnfkbactivation AT amininsha zingerone44hydroxy3methylphenylbutan2oneprotectsagainstalloxaninduceddiabetesviaalleviationofoxidativestressandinflammationprobableroleofnfkbactivation AT mirmanzoorurrahman zingerone44hydroxy3methylphenylbutan2oneprotectsagainstalloxaninduceddiabetesviaalleviationofoxidativestressandinflammationprobableroleofnfkbactivation AT ahmadsheikhbilal zingerone44hydroxy3methylphenylbutan2oneprotectsagainstalloxaninduceddiabetesviaalleviationofoxidativestressandinflammationprobableroleofnfkbactivation AT farooqadil zingerone44hydroxy3methylphenylbutan2oneprotectsagainstalloxaninduceddiabetesviaalleviationofoxidativestressandinflammationprobableroleofnfkbactivation AT muzamilshowkeen zingerone44hydroxy3methylphenylbutan2oneprotectsagainstalloxaninduceddiabetesviaalleviationofoxidativestressandinflammationprobableroleofnfkbactivation AT hussainishraq zingerone44hydroxy3methylphenylbutan2oneprotectsagainstalloxaninduceddiabetesviaalleviationofoxidativestressandinflammationprobableroleofnfkbactivation AT masoodimubashir zingerone44hydroxy3methylphenylbutan2oneprotectsagainstalloxaninduceddiabetesviaalleviationofoxidativestressandinflammationprobableroleofnfkbactivation AT fatimabilques zingerone44hydroxy3methylphenylbutan2oneprotectsagainstalloxaninduceddiabetesviaalleviationofoxidativestressandinflammationprobableroleofnfkbactivation |